Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FOXA1 is a determinant of drug resistance in breast cancer cells

8 Jan 2021

Abstract excerpt

PURPOSE: Breast cancer is one of the most commonly diagnosed cancers in women. Five subtypes of breast cancer differ in their genetic expression profiles and carry different prognostic values, with no treatments available for some types, such as triple-negative, due to the absence of genetic signatures that could otherwise be targeted by molecular therapies. Although endocrine treatments are largely successful...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Estrogen and related hormone effects
Share to FOXO transcription factor regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33417085
DOI: 10.1007/s10549-020-06068-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FOXA1 is a determinant of drug resistance in breast cancer cellsPMID 33417085Read ↗

A combined approach on the impact of EP300 overexpression on drug resistance, invasion and stemness in breast cancerSemantic proximity Read ↗

Characterizing novel molecular mechanisms involved in breast cancer tumourigenesis/progression and tamoxifen resistanceSemantic proximity Read ↗

FOXA1 as a therapeutic target for breast cancerSemantic proximity Read ↗

A Unique FOXA1-Associated Chromatin State Dictates Therapeutic Resistance in Lobular Breast CancerSemantic proximity Read ↗

Transcriptional Shift Identifies a Set of Genes Driving Breast Cancer ChemoresistanceSemantic proximity Read ↗

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerSemantic proximity Read ↗

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancerSemantic proximity Read ↗

FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repairSemantic proximity Read ↗

AFF3 upregulation mediates tamoxifen resistance in breast cancersSemantic proximity Read ↗

Flavopiridol inhibits FOXM1/NF-kB and KRAS/MAPK signaling and DNA repair mechanims and Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin theSemantic proximity Read ↗

FOXA1 represses the molecular phenotype of basal breast cancer cells.Semantic proximity Read ↗

FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.